Gyre Therapeutics
GYRE
GYRE
44 hedge funds and large institutions have $23.6M invested in Gyre Therapeutics in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $85K
Holders
44
Holding in Top 10
–
Calls
–
Puts
$85K
Top Buyers
| 1 | +$470K | |
| 2 | +$394K | |
| 3 | +$375K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$353K |
| 5 |
Morgan Stanley
New York
|
+$351K |
Top Sellers
| 1 | -$267K | |
| 2 | -$111K | |
| 3 | -$110K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$103K |
| 5 |
Jane Street
New York
|
-$100K |
